Antibiotic resistance and vaccination in patients with urinary tract infection
Journal Title: Нирки - Year 2018, Vol 7, Issue 1
Abstract
Limited in experience of using uroantiseptics, even those manufactured in European countries, such as Furamag and Macmiror, excessive use of antibiotics, which causes antibiotic resistance in the EU countries and form resistance to antibiotics. The problem of treatment resistant, recurrent infections of the urinary tract and asymptomatic bacteriuria can be solved with vaccinotherapy. Urivac may recommend as an independent option or in combination with prophylactic treatment with uroanticeptic and/or phytomedicine.
Authors and Affiliations
D. D. Ivanov
Keywords
Related Articles
- EP ID EP265050
- DOI 10.22141/2307-1257.7.1.2018.122213
- Views 84
- Downloads 0
The Use of Extracts of Goldenrod (Solidago Virgaurea L.) for the Treatment of Diseases of the Urinary Tract
This review examines the pharmacological and clinical data on the use of extracts of goldenrod (Solidago virgaurea L.) for the treatment of diseases of the urinary system. Goldenrod extracts exhibit 6 major pharmacologic...
Drug treatment of urolithiasis using citrate therapy
Urolithiasis - disease, morphological substrate of which is the formation of stones in the urinary tract and related changes in the urinary tract. The disease is characterized by its prevalence and a variety of etiologic...
Adsorptive-Rheological Properties of Blood Serum in Gouty Nephropathy
The aim and tasks of the study — to evaluate clinical-pathogenetic significance of changes in adsorptive rheological properties of blood serum (ARPB) in patients with different clinical courses of gouty nephropathy. Mate...
Diagnostic Role of N-Acetyl-β-D-Glucosaminidase as an Early Marker of Kidney Damage
In many diseases of the kidneys, N-acetyl-β-D-glucosaminidase (NAG) in the urine is excreted in large quantities. A significant increase in NAG activity is observed at the primary and secondary kidney damage, heavy metal...
Immunoadsorption and Its Application for Desensitizing Incompatible Kidney Transplant Candidates Who Have a Potential Living Donor
Background. Plasmapheresis is widely used to remove potential deleterious antibodies from the blood. Because the volume of treated plasma is limited, plasmapheresis can be replaced by immunoadsorption (IA), a more tediou...